Cleared Traditional

Pitch-Patchs (K211563) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211563 · Xiros, Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2021
Decision
85d
Days
Class 2
Risk

K211563 is an FDA 510(k) clearance for the Pitch-Patchs. Classified as Mesh, Surgical, Polymeric (product code FTL), Class II - Special Controls.

Submitted by Xiros, Ltd. (Leeds, GB). The FDA issued a Cleared decision on August 13, 2021 after a review of 85 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3300 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Xiros, Ltd. devices

Submission Details

510(k) Number K211563 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 20, 2021
Decision Date August 13, 2021
Days to Decision 85 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 115d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FTL Mesh, Surgical, Polymeric
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FTL Mesh, Surgical, Polymeric

All 130
Devices cleared under the same product code (FTL) and FDA review panel - the closest regulatory comparables to K211563.
Poly-Tape/Infinity-Lock Soft Tissue Reinforcement Device
K220091 · Xiros, Ltd. · Aug 2022
Symbotex Composite Mesh, ProGrip Self-Gripping Polyester Mesh, Parietex Hydrophilic 2D 3D Anatomical Mesh, Versatex Monofilament Mesh
K220586 · Sofradim Production · Jun 2022
ARISTE AB Mesh
K211132 · Ariste Medical, LLC · Mar 2022
SurgiWrap FROST
K200918 · Mast Biosurgery · Jan 2021
VICRYL Mesh
K201143 · Ethicon, Inc. · Aug 2020
3DMax MID Anatomical Mesh
K200818 · C.R. Bard, Inc. · Jul 2020